563080 Sigma-AldrichSalinomycin
Salinomycin reduces the proportion of cancer stem cells(CSC) by >100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug.
More>> Salinomycin reduces the proportion of cancer stem cells(CSC) by >100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug. Less<<Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
53003-10-4 | C₄₂H₇₀O₁₁ |
References | |
---|---|
References | Gupta, P.B., et al. 2009. Cell. 138, 1. |
Product Information | |
---|---|
CAS number | 53003-10-4 |
Form | White to white with yellow cast |
Hill Formula | C₄₂H₇₀O₁₁ |
Chemical formula | C₄₂H₇₀O₁₁ |
Hygroscopic | Hygroscopic |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information | |
---|---|
R Phrase | R: 25 Toxic if swallowed. |
S Phrase | S: 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
563080 | 0 |
Documentation
Salinomycin MSDS
Title |
---|
Salinomycin Certificates of Analysis
Title | Lot Number |
---|---|
563080 |
References
Reference overview |
---|
Gupta, P.B., et al. 2009. Cell. 138, 1. |